NeOnc Technologies Holdings (NTHI)
2.77
0.00 (0.00%)
Upcoming Events
Latest Headlines
NeOnc Technologies and the Department of Health – Abu Dhabi Sign MoU to Advance Brain Cancer Research and Proposed Clinical Collaboration
October 21, 2026 8:00 AM - StreetInsider
Forget the Ugly Sweaters and Ugly Charts, NeOnc is Ready for Catalyst Season
October 20, 2026 9:33 AM - Globe NewsWire
NeOnc's Most Challenging Test Yet: Compassionate-Use Update Puts NEO100's Potential in Focus
October 16, 2026 9:28 AM - StreetInsider
NeOnc’s Boldest Test Yet: Child’s Early Improvement Puts NEO100 in the Spotlight with Compassionate-Use Milestone
October 16, 2026 8:56 AM - Globe NewsWire
NeOnc reports early signs of improvement in child treated with NEO100
October 16, 2026 8:01 AM - StreetInsider
NeOnc Reports Early Clinical Improvement in First Child Treated with NEO100 Under Compassionate Use in Abu Dhabi
October 16, 2026 8:00 AM - StreetInsider
Form 3 NEONC TECHNOLOGIES HOLDI For: Oct 09 Filed by: ALABEDIN ALI MOHAMMAD AHMAD MOHAMMAD
October 15, 2026 9:33 PM - SEC Filing
Form 8-K NEONC TECHNOLOGIES HOLDI For: Oct 09
October 15, 2026 4:30 PM - SEC Filing
From Shaq to Musk: The Power Appointment Effect
October 15, 2026 9:35 AM - StreetInsider
UAE Banking Heavyweight Joins NeOnc as Global Brain-Cancer Drug Development Advances
October 15, 2026 8:57 AM - Globe NewsWire
NeOnc CEO Amir F. Heshmatpour to Address Global Life Sciences Investment at Abu Dhabi Future Health Summit 2026
October 15, 2026 8:00 AM - StreetInsider
NeOnc Strengthens Boardroom Firepower as Abu Dhabi Opens a New Path for Brain Cancer Drug Development
October 14, 2026 10:18 AM - Globe NewsWire
NeOnc Technologies adds First Abu Dhabi Bank executive to its board
October 14, 2026 8:00 AM - StreetInsider
NeOnc Technologies Appoints Ali Alabedin to Its Board of Directors
October 14, 2026 8:00 AM - StreetInsider
2026 Takes a Promising Turn in the Fight Against Cancer as Five Advances Offer New Hope
October 7, 2026 10:00 AM - StreetInsider
NeOnc among Names with 2026 Breakthroughs that Offer New Hope in the Fight Against Cancer
October 7, 2026 9:43 AM - Globe NewsWire
NeOnc’s FDA Catalyst Run Could Give NTHI a Serious Jolt
October 6, 2026 9:02 AM - Globe NewsWire
Biotech Brainiacs and Breakthroughs
October 5, 2026 9:52 AM - StreetInsider
These High-Voltage Stocks Are Suddenly Impossible to Ignore
October 2, 2026 11:45 AM - StreetInsider
3 Biotech Stocks Throwing Their Weight Around, and Another that Wants to Help You Lose Yours
September 30, 2026 10:23 AM - StreetInsider
High-Stakes October has these Biotechs Entering Crucial Stretch
September 29, 2026 12:13 PM - StreetInsider
NeOnc’s Powerful Brain Cancer Pipeline Advances
September 29, 2026 8:52 AM - Globe NewsWire
Form 8-K NEONC TECHNOLOGIES HOLDI For: Sep 28
September 28, 2026 5:00 PM - SEC Filing
4 Explosive Stories Enter the Investor Spotlight
September 28, 2026 11:52 AM - StreetInsider
Powerful NeOnc Brain Cancer Pipeline Advances
September 28, 2026 9:51 AM - Globe NewsWire
NeOnc schedules FDA meeting for NEO212 Phase 2 design review
September 28, 2026 8:01 AM - StreetInsider
NeOnc Technologies Announces FDA End of Phase 1 Meeting for NEO212
September 28, 2026 8:00 AM - StreetInsider
Here’s What Investors Are Watching, Including $20 Price Target Bombshell
September 24, 2026 11:44 AM - StreetInsider
NeOnc Lands New Coverage and Roth Sees Potential 2026 Trial Catalyst
September 24, 2026 10:21 AM - StreetInsider
NeOnc Lands New Coverage and Roth Sees Potential 2026 Trial Catalyst
September 24, 2026 10:20 AM - Globe NewsWire
Roth/MKM Starts NeOnc Technologies (NTHI) at Buy
September 24, 2026 3:11 AM - StreetInsider
NeOnc’s Delivery may Finally Change the Equation for Brain Cancer’s Next Frontier
September 22, 2026 2:52 PM - Globe NewsWire
Today’s Best Stocks to Watch: Weight-Loss Wars, Biotech and Critical Minerals
September 22, 2026 10:32 AM - StreetInsider
Form 8-K NEONC TECHNOLOGIES HOLDI For: Sep 15
September 21, 2026 4:31 PM - SEC Filing
NeOnc Charting New Nasal Route to Treating Brain Cancer
September 21, 2026 8:00 AM - Globe NewsWire
Form 4 NEONC TECHNOLOGIES HOLDI For: Sep 15 Filed by: GARNETT KEITHLY
September 18, 2026 9:26 PM - SEC Filing
Four High-Impact Small Caps Enter the Spotlight
September 17, 2026 11:38 AM - StreetInsider
NeOnc Eliminates Major Dilution Risk as Clinical Story Accelerates
September 17, 2026 8:54 AM - Globe NewsWire
NeOnc redeems $6M in preferred stock with cash, avoiding dilution
September 17, 2026 8:02 AM - StreetInsider
NeOnc Technologies Redeems All Outstanding Series A Convertible Preferred Stock and Eliminates Related Potential Dilution
September 17, 2026 8:00 AM - StreetInsider
Form 8-K NEONC TECHNOLOGIES HOLDI For: Sep 16
September 17, 2026 6:03 AM - SEC Filing
NeOnc’s $629K Insider Buying Spree Follows Breakthrough Data and Now All Eyes Turn to the FDA
September 16, 2026 8:46 AM - Globe NewsWire
NeOnc executives buy $629,000 in stock after NEO100 trial results
September 16, 2026 8:00 AM - StreetInsider
NeOnc Executives Invest Approximately $629,000 in Open-Market Stock Purchases Following Positive NEO100 Phase 2a Results
September 16, 2026 8:00 AM - StreetInsider
Form 4 NEONC TECHNOLOGIES HOLDI For: Sep 14 Filed by: Heshmatpour Amir F
September 15, 2026 8:48 PM - SEC Filing
Form 4 NEONC TECHNOLOGIES HOLDI For: Sep 11 Filed by: CHEN THOMAS C
September 15, 2026 8:45 PM - SEC Filing
Form 4 NEONC TECHNOLOGIES HOLDI For: Sep 14 Filed by: GARNETT KEITHLY
September 15, 2026 8:45 PM - SEC Filing
Form 144 NEONC TECHNOLOGIES HOLDI Filed by: GARNETT KEITHLY
September 15, 2026 4:44 PM - SEC Filing
Investor Determination to Beat Cancer Puts NeOnc’s Novel Therapies and Patented Platform in Focus
September 15, 2026 9:53 AM - Globe NewsWire
Insiders Continue Buying, as NeOnc Moves NEO100 Toward Its Next Regulatory Test
September 14, 2026 9:07 AM - Globe NewsWire
Form 4 NEONC TECHNOLOGIES HOLDI For: Sep 11 Filed by: Heshmatpour Amir F
September 14, 2026 6:03 AM - SEC Filing
Three Nasdaq Cancer Developers Under $10 Advance Clinical Programs
September 11, 2026 8:45 AM - StreetInsider
Big Pharma Setbacks Create a New Wave of Rebound Plays
September 10, 2026 2:13 PM - StreetInsider
Form 8-K NEONC TECHNOLOGIES HOLDI For: Sep 08
September 10, 2026 10:28 AM - SEC Filing
Form 424B5 NEONC TECHNOLOGIES HOLDI
September 10, 2026 10:25 AM - SEC Filing
Four Biotech Stories Heating Up Right Now
September 9, 2026 11:56 AM - StreetInsider
NeOnc raises $15M in registered direct offering amid Phase 2a data
September 9, 2026 9:36 AM - StreetInsider
NeOnc Raises $15 Million At Market Adding Fuel to the Strong NEO100 Data
September 9, 2026 9:35 AM - Globe NewsWire
NeOnc Technologies prices $15M direct offering at $4.20 per share
September 9, 2026 8:00 AM - StreetInsider
NeOnc Technologies Holdings, Inc. Announces Pricing of $15 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules with New and Existing Institutional Investors
September 9, 2026 8:00 AM - StreetInsider
NeOnc' Phase 2 Data Could Put Cancer on the Ropes
September 8, 2026 8:40 AM - StreetInsider
NeOnc reports Phase 2a brain cancer trial results, plans FDA meeting
August 28, 2026 10:08 AM - StreetInsider
NeOnc’s Phase 2A Success Could Set the Stage for Something Much Bigger
August 28, 2026 10:07 AM - Globe NewsWire
NeOnc’s Clinical Story Is Now the Main Event
August 26, 2026 9:39 AM - Globe NewsWire
Form 8-K/A NEONC TECHNOLOGIES HOLDI For: Jun 27
August 21, 2026 2:59 PM - SEC Filing
Form 4 NEONC TECHNOLOGIES HOLDI For: Aug 18 Filed by: CHEN THOMAS C
August 20, 2026 9:16 PM - SEC Filing
Form 4/A NEONC TECHNOLOGIES HOLDI For: Apr 10 Filed by: CHEN THOMAS C
August 20, 2026 9:15 PM - SEC Filing
Form 8-K NEONC TECHNOLOGIES HOLDI For: Aug 14
August 20, 2026 9:00 AM - SEC Filing
Form 4 NEONC TECHNOLOGIES HOLDI For: Apr 09 Filed by: CHEN THOMAS C
August 18, 2026 4:14 PM - SEC Filing
Form 4 NEONC TECHNOLOGIES HOLDI For: Aug 18 Filed by: Heshmatpour Amir F
August 18, 2026 2:31 PM - SEC Filing
NeOnc Technologies- Talk Is Cheap, Insider Buying Isn’t
August 18, 2026 10:18 AM - Globe NewsWire
Form 4 NEONC TECHNOLOGIES HOLDI For: Aug 14 Filed by: Heshmatpour Amir F
August 17, 2026 6:50 PM - SEC Filing
These Nasdaq Stories Are Heating Up
August 17, 2026 3:27 PM - StreetInsider
NTHI’s Nasdaq Advantage Takes on New Meaning After Its Breakthrough Phase 2a Results
August 17, 2026 8:45 AM - Globe NewsWire
New to The Street Airs This Weekend Across Bloomberg Television U.S., Latin America and MENA
August 15, 2026 10:41 AM - StreetInsider
These Biotech Breakouts and Squeeze Setups Could Be Just Getting Started
August 14, 2026 1:14 PM - StreetInsider
Form 8-K NEONC TECHNOLOGIES HOLDI For: Aug 12
August 13, 2026 5:21 PM - SEC Filing
Stonegate Capital Partners Updates Coverage on NeOnc Technologies Holdings, Inc. (NTHI) 2Q26
August 13, 2026 4:20 PM - StreetInsider
The Nose Knows: Why NeOnc’s Patent Portfolio Could Make NTHI More Than a One-Drug Biotech
August 13, 2026 2:31 PM - Globe NewsWire
Powerful Catalysts Sending These Stocks into High Gear
August 12, 2026 2:11 PM - StreetInsider
Targeting The Mutant: NTHI’s NEO100 Data Could Open a New Front in the Fight Against Brain Cancer
August 12, 2026 9:38 AM - Globe NewsWire
NeOnc Phase 2a brain cancer trial shows 48.9% survival vs. 20% benchmark
August 12, 2026 9:27 AM - StreetInsider
NeOnc's NEO100 Phase 2a Brain Cancer Study Beats Historical Benchmark by Nearly 2.5x
August 12, 2026 9:27 AM - StreetInsider
Form 8-K NEONC TECHNOLOGIES HOLDI For: Aug 12
August 12, 2026 8:32 AM - SEC Filing
NeOnc phase 2a trial of intranasal NEO100 meets primary endpoint
August 12, 2026 8:00 AM - StreetInsider
NeOnc Technologies Reports Positive Topline Phase 2a Results for Intranasal NEO100 in Recurrent IDH1-Mutant High-Grade Glioma
August 12, 2026 8:00 AM - StreetInsider
NeOnc Technologies Holdings (NTHI) Halted, News Pending
August 12, 2026 7:55 AM - StreetInsider
These Have the Market Hot Zone Catalysts and Setups
August 11, 2026 4:52 PM - StreetInsider
Breakout Stocks and Next Big Movers Could Be Taking Shape Now
August 11, 2026 2:45 PM - StreetInsider
NeOnc Approaches a Major Biotech Inflection Point as tomorrow’s Brain-Cancer Data is set to Collide with a Tight Float
August 11, 2026 11:01 AM - StreetInsider
NTHI Brain Cancer Phase 2 Data Expected to Spark Triple Confluence
August 11, 2026 8:46 AM - StreetInsider
Form 8-K NEONC TECHNOLOGIES HOLDI For: Aug 10
August 10, 2026 5:15 PM - SEC Filing
NeOnc Technologies Holdings (NTHI) Reports Q2 Loss of $0.58
August 10, 2026 4:16 PM - StreetInsider
The Catalysts are Back: Socket Mobile Breaks Out while Biotechs Race Toward Major Milestones
August 10, 2026 10:40 AM - StreetInsider
NeOnc to release NEO100 Phase 2a trial data on August 12
August 10, 2026 10:34 AM - StreetInsider
NeOnc Heads into a High-Stakes Week as Highly Anticipated NEO100 Phase 2a Data Readout Nears
August 10, 2026 10:34 AM - Globe NewsWire
Form 10-Q NEONC TECHNOLOGIES HOLDI For: Jun 30
August 10, 2026 9:01 AM - SEC Filing
NeOnc posts wider Q2 loss, plans NEO100 trial data release Aug. 12
August 10, 2026 9:00 AM - StreetInsider
NeOnc Reports Second Quarter 2026 Financial Results and Confirms August 12 Topline Phase 2a NEO100 Data Readout
August 10, 2026 9:00 AM - StreetInsider
NeOnc Technologies to discuss Phase 2a glioma trial results Aug. 12
August 10, 2026 8:30 AM - StreetInsider
NeOnc Technologies to Host Investor Conference Call to Discuss Topline Phase 2a Results for Intranasal NEO100 in Recurrent IDH1-Mutant High-Grade Glioma
August 10, 2026 8:30 AM - StreetInsider
Why Investors Are Watching These Healthcare Movers
August 6, 2026 12:32 PM - StreetInsider
NeOnc Technologies adds strategy executive Nasim Shomali to its board
July 27, 2026 9:00 AM - StreetInsider
NeOnc Technologies Appoints Strategy and Finance Executive Nasim Shomali to its Board of Directors
July 27, 2026 9:00 AM - StreetInsider
Full Article List
